Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
How Deforestation Is Reshaping Mosquito-Human Contact - 2Iran's stolen futures: The arrested Iranians at risk of execution by the regime
- 3The most effective method to Quick Track Your Outcome in Advanced Showcasing with a Web-based Degree
- 4Instructions to Utilize Your Brain science Certification to Work on Corporate Culture
- 5NASA’s Artemis II mission will take an astronaut crew around the Moon – a space policy expert describes the long road to launch
- Drenched in Pixels: A Survey of \Vivid Interactivity Experience\ Game
- Watch interstellar comet 3I/ATLAS speed away from the sun in free telescope livestream on Nov. 16
- The most effective method to Connect Successfully with Teachers in a Web based Setting
- ‘Wu-Tang Forever: The Final Chamber’ tour — How to get tickets, presale times, concert dates and more
- Netanyahu leads meeting on West Bank riots, Katz defends axing administrative detention for Jews
- Vote in favor of your Number one Kind of Gems
- With Obamacare premium hikes, more people opting for no coverage or cheaper plans
- The Reduced Portage Horse: An Inheritance Reconsidered for Present day Experience
- Vaccine committee votes to scrap universal hepatitis B shots for newborns despite outcry from children’s health experts
